Avanos Medical, Inc. (AVNS) is a publicly traded Healthcare sector company. As of May 21, 2026, AVNS trades at $24.74 with a market cap of $1.16B and a P/E ratio of -2.90. AVNS moved -0.04% today. Year to date, AVNS is +118.74%; over the trailing twelve months it is +88.86%. Its 52-week range spans $9.30 to $24.91. Rallies surfaces AVNS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for AVNS shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $24.74 |
| Market Cap | $1.16B |
| P/E Ratio | -2.90 |
| EPS | $-8.53 |
| Dividend Yield | 0.00% |
| 52-Week High | $24.91 |
| 52-Week Low | $9.30 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $687.80M |
| Net Income | $-392.10M |
| Gross Margin | 55.44% |
AVNS analyst coverage data. Average price target: $0.00.